Law360, New York (October 1, 2015, 11:05 PM EDT) -- An Ohio federal judge on Wednesday ruled that GlaxoSmithKline must face a product liability suit brought by a woman whose child was born with heart defects after she took the antidepressant Paxil during her pregnancy, ruling that she had successfully pled fraud.
U.S. District Judge Edmund A. Sargus denied GlaxoSmithKline LLC.’s motion for judgment on the pleadings, rejecting its argument that plaintiff Kathryn Kiker’s claims accrued in September 2005, when the company told the medical community about the serious risks of birth defects, and are thus abrogated by the Ohio Product Liability Act, which was amended in 2005 and abrogate common law...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!